All targeted protein degradation articles
-
Opinion
Being wrong is almost inevitable
On the tightrope of expressing your opinion, you always risk looking a fool
-
Business
Pfizer backs protein degrader drugs with Arvinas deal
$1bn investment to commercialise breast cancer treatment
-
Webinar
Developing small-molecule degraders using chemoproteomics
Discover how chemoproteomics can inform the development of small molecule degraders
-
Webinar
Targeted protein degradation using small molecules
Learn how Protacs work for targeted protein degradation to widen the spectrum of targetable proteins